Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$16.60 USD
+0.16 (0.97%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $16.61 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVDL 16.60 +0.16(0.97%)
Will AVDL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AVDL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVDL
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know
AVDL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Invest in Avadel (AVDL) Stock Now
Avadel (AVDL) is a Great Momentum Stock: Should You Buy?
How Much Upside is Left in Avadel (AVDL)? Wall Street Analysts Think 37.36%
Other News for AVDL
Avadel Pharmaceuticals to Join Russell 3000® Index
Avadel Pharmaceuticals Joins the Russell 3000® Index
Avadel Pharmaceuticals to join Russell 3000 index
Avadel Pharmaceuticals to join Russell 3000 Index
Jazz Pharmaceuticals: Pipeline Setback While Business Transition Continues